Anti-SNN monoclonal antibody

Pre-made anti-SNN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SNN/SNN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1780-Ab-1/ GM-Tg-hg-IP1780-Ab-2Anti-Human SNN monoclonal antibodyHuman
GM-Tg-rg-IP1780-Ab-1/ GM-Tg-rg-IP1780-Ab-2Anti-Rat SNN monoclonal antibodyRat
GM-Tg-mg-IP1780-Ab-1/ GM-Tg-mg-IP1780-Ab-2Anti-Mouse SNN monoclonal antibodyMouse
GM-Tg-cynog-IP1780-Ab-1/ GM-Tg-cynog-IP1780-Ab-2Anti-Cynomolgus/ Rhesus macaque SNN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1780-Ab-1/ GM-Tg-felg-IP1780-Ab-2Anti-Feline SNN monoclonal antibodyFeline
GM-Tg-cang-IP1780-Ab-1/ GM-Tg-cang-IP1780-Ab-2Anti-Canine SNN monoclonal antibodyCanine
GM-Tg-bovg-IP1780-Ab-1/ GM-Tg-bovg-IP1780-Ab-2Anti-Bovine SNN monoclonal antibodyBovine
GM-Tg-equg-IP1780-Ab-1/ GM-Tg-equg-IP1780-Ab-2Anti-Equine SNN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1780-Ab-1/ GM-Tg-hg-IP1780-Ab-2; GM-Tg-rg-IP1780-Ab-1/ GM-Tg-rg-IP1780-Ab-2;
GM-Tg-mg-IP1780-Ab-1/ GM-Tg-mg-IP1780-Ab-2; GM-Tg-cynog-IP1780-Ab-1/ GM-Tg-cynog-IP1780-Ab-2;
GM-Tg-felg-IP1780-Ab-1/ GM-Tg-felg-IP1780-Ab-2; GM-Tg-cang-IP1780-Ab-1/ GM-Tg-cang-IP1780-Ab-2;
GM-Tg-bovg-IP1780-Ab-1/ GM-Tg-bovg-IP1780-Ab-2; GM-Tg-equg-IP1780-Ab-1/ GM-Tg-equg-IP1780-Ab-2
Products NameAnti-SNN monoclonal antibody
Formatmab
Target NameSNN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SNN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1780-Ag-1Recombinant multi-species SNN protein
    ORF Viral VectorpGMLP000852human SNN Lentivirus plasmid
    ORF Viral VectorvGMLP000852human SNN Lentivirus particle
    ORF Viral VectorpGMLPm000281mouse Snn Lentivirus plasmid
    ORF Viral VectorvGMLPm000281mouse Snn Lentivirus particle


    Target information

    Target IDGM-IP1780
    Target NameSNN
    Gene ID8303,20621,29140,711909,609847,101083312,615361,100051037
    Gene Symbol and Synonyms2810407J07Rik,SNN
    Uniprot AccessionO75324,P61808,Q17Q87
    Uniprot Entry NameSNN_HUMAN,SNN_RAT,SNN_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184602
    Target ClassificationN/A

    The target: SNN, gene name: SNN, also named as . Enables metal ion binding activity. Predicted to be involved in response to toxic substance. Located in cytoplasm. Is integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.